Eur Rev Med Pharmacol Sci 2021; 25 (5): 2156-2156

DOI: 10.26355/eurrev_202103_25197

MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2

M.-Z. Pan, Y.-L. Song, F. Gao

Department of Urology Surgery, The Seventh People’s Hospital of Jinan, Jinan, China.

 


We detected some serious inaccuracies and mistakes. Therefore, the article “MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2, by M.-Z. Pan, Y.-L. Song, F. Gao, published in Eur Rev Med Pharmacol Sci 2019; 23 (20): 8795-8805–DOI: 10.26355/eurrev_201910_19274–PMID: 31696466” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2

Free PDF Download

To cite this article

M.-Z. Pan, Y.-L. Song, F. Gao
MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 5
Pages: 2156-2156
DOI: 10.26355/eurrev_202103_25197